DrugPatentWatch Database Preview
OZURDEX Drug Profile
see a sample report or, see our see our flat-rate plans
When do Ozurdex patents expire, and what generic alternatives are available?
Ozurdex is a drug marketed by Allergan and is included in one NDA. There are fifteen patents protecting this drug.
The generic ingredient in OZURDEX is dexamethasone. There are thirty-nine drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the dexamethasone profile page.
Summary for OZURDEX
| US Patents: | 15 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 87 |
| Clinical Trials: | 59 |
| Patent Applications: | 4,587 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for OZURDEX |
| DailyMed Link: | OZURDEX at DailyMed |
Pharmacology for OZURDEX
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for OZURDEX
Synonyms for OZURDEX
| .delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol |
| .gamma.corten |
| (11|A,16|A)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione; 9|A-Fluoro-16|A-methyl-11|A,17|A,21-trihydroxy-1,4-pregnadiene-3,20-dione; 9|A-Fluoro-16|A-methylprednisolone; Prednisolone F |
| (11beta,16alpha)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione |
| (11beta,16alpha)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione labeled with tritium |
| (1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one |
| (1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-3,6-dien-5-one |
| (1R,2S,10S,11S,13R,14R,15S,17S)-1-FLUORO-14,17-DIHYDROXY-14-(2-HYDROXYACETYL)-2,13,15-TRIMETHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-5-ONE |
| (1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0(2),.0(1)(1),(1)]heptadeca-3,6-dien-5-one |
| (2S,10S,11S,15S,17S,1R,13R,14R)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)- 2,13,15-trimethyltetracyclo[8.7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-5-one |
| (3H)-Dexamethasone |
| (8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one |
| (8S,9R,10S,11S,13S,14S,16R,17R)-9-Fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]ph |
| (8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
| [3H]-dexamethasone |
| [3H]dexamethasone |
| 064D136 |
| 1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone |
| 1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone |
| 1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone |
| 1050677-47-8 |
| 137098-19-2 |
| 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione |
| 16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol |
| 16-alpha-Methyl-9-alpha-fluoro-1,4-pregnadiene-11-beta,17-alpha,21-triol-3,20-dione |
| 16-alpha-Methyl-9-alpha-fluoro-11-beta,17-alpha,21-trihydroxypregna-1,4-diene-3,20-dione |
| 16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone |
| 16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone |
| 16-alpha-Methyl-9-alpha-fluoroprednisolone |
| 16.alpha.-Methyl-9.alpha.-fluoro-.delta.(sup1)-hydrocortisone |
| 16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol |
| 16.alpha.-Methyl-9.alpha.-fluoro-11.beta.-17.alpha.-21-trihydroxypregna-1,20-dione |
| 16.alpha.-Methyl-9.alpha.-fluoroprednisolone |
| 16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol |
| 16alpha -Methyl-9alpha -fluoroprednisolone |
| 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol |
| 16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone |
| 16alpha-Methyl-9alpha-fluoroprednisolone |
| 1793-EP2269977A2 |
| 1793-EP2269989A1 |
| 1793-EP2269990A1 |
| 1793-EP2270008A1 |
| 1793-EP2270014A1 |
| 1793-EP2270018A1 |
| 1793-EP2272832A1 |
| 1793-EP2275420A1 |
| 1793-EP2277565A2 |
| 1793-EP2277566A2 |
| 1793-EP2277567A1 |
| 1793-EP2277568A2 |
| 1793-EP2277569A2 |
| 1793-EP2277570A2 |
| 1793-EP2277861A1 |
| 1793-EP2277865A1 |
| 1793-EP2277876A1 |
| 1793-EP2279741A2 |
| 1793-EP2281563A1 |
| 1793-EP2289894A2 |
| 1793-EP2292227A2 |
| 1793-EP2292280A1 |
| 1793-EP2292589A1 |
| 1793-EP2292614A1 |
| 1793-EP2292617A1 |
| 1793-EP2295055A2 |
| 1793-EP2295402A2 |
| 1793-EP2295409A1 |
| 1793-EP2295412A1 |
| 1793-EP2295413A1 |
| 1793-EP2295416A2 |
| 1793-EP2298731A1 |
| 1793-EP2298743A1 |
| 1793-EP2298748A2 |
| 1793-EP2298764A1 |
| 1793-EP2298765A1 |
| 1793-EP2298772A1 |
| 1793-EP2298778A1 |
| 1793-EP2298779A1 |
| 1793-EP2298780A1 |
| 1793-EP2305248A1 |
| 1793-EP2305642A2 |
| 1793-EP2305663A1 |
| 1793-EP2305689A1 |
| 1793-EP2308562A2 |
| 1793-EP2308812A2 |
| 1793-EP2308833A2 |
| 1793-EP2308839A1 |
| 1793-EP2308880A1 |
| 1793-EP2311453A1 |
| 1793-EP2314585A1 |
| 1793-EP2314590A1 |
| 1793-EP2316459A1 |
| 1793-EP2316832A1 |
| 1793-EP2316833A1 |
| 1793-EP2316834A1 |
| 1793-EP2371811A2 |
| 1p93 |
| 23495-06-9 |
| 4-alpha-Fluoro-16-alpha-methyl-11-beta,17,21-trihydroxypregna-1,4-diene-3,20-dione |
| 4.alpha.-Fluoro-16.alpha.-methyl-11.beta.-17,4-diene-3,20-dione |
| 50-02-2 |
| 7S5I7G3JQL |
| 8054-59-9 |
| 9-alpha-Fluoro-16-alpha-methyl-1,4-pregnadiene-11-beta,17-alpha,21-triol-3,20-dione |
| 9-alpha-Fluoro-16-alpha-methylprednisolone |
| 9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione |
| 9-Fluoro-11.beta.,21-trihydroxy-16.alpha.-methylpregna-1,4-diene-3,20-dione |
| 9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione |
| 9-Fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione |
| 9-Fluoro-16-methylprednisolone |
| 9-fluoro-16alpha-methyl-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione |
| 9.alpha.-Fluoro-11.beta.-17.alpha.- 21-trihydroxy-16.alpha.-methylpregna-1,20-dione |
| 9.alpha.-Fluoro-16.alpha.-methyl-1,20-dione |
| 9.alpha.-Fluoro-16.alpha.-methyl-11.beta.,21.beta.-trihydroxy-pregna-1,4-diene-3,20-dione |
| 9.alpha.-Fluoro-16.alpha.-methylprednisolone |
| 906362-70-7 |
| 906422-84-2 |
| 9a-Fluoro-11b,17a,21-trihydroxy-16a-methylpregna-1,4-diene-3,20-dione |
| 9A-FLUORO-16BETA-METHYLPREDNISOLONE |
| 9alpha -Fluoro-16alpha -methylprednisolone |
| 9alpha-Fluoro-16alpha-methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione |
| 9alpha-fluoro-16alpha-methyl-Prednisolone |
| 9alpha-Fluoro-16alpha-methylprednisolone |
| AB0072035 |
| AB00918428_10 |
| AB00918428-05 |
| AB00918428-08 |
| AB00918428-09 |
| AB1009273 |
| AC-11056 |
| AC1L1L1H |
| AC1Q29DM |
| ACN-036253 |
| Adexone |
| Aeroseb-D |
| Aeroseb-Dex |
| AI3-50934 |
| AJ-46415 |
| Ak Dex Oph Otic Soln 0.1% |
| AK126741 |
| AK402468 |
| AKOS005259009 |
| AKOS015895509 |
| Alcon Brand of Dexamethasone |
| alpha -Fluoro-16-alpha -methylcortisol |
| Anaflogistico |
| Aphtasolon |
| Aphthasolone |
| Apo-dexamethasone |
| ARONIS27003 |
| Auxiron |
| Azimycin (Veterinary) |
| Azium |
| Azium (Veterinary) |
| BC201625 |
| BDBM18207 |
| BIDD:ER0494 |
| BIDD:PXR0060 |
| Bisu DS |
| BRD-K38775274-001-02-3 |
| BRD-K38775274-001-06-4 |
| BSPBio_000995 |
| C15643 |
| C22H29FO5 |
| Calonat |
| CAS-50-02-2 |
| CCRIS 7067 |
| CHEBI:41879 |
| CHEMBL384467 |
| Corson |
| Corsone |
| Cortisumman |
| CS-1505 |
| D00292 |
| D0IT2G |
| DB01234 |
| Decacort |
| Decacortin |
| Decaderm |
| Decadron |
| Decadron (TN) |
| Decadron phosphate, Decdan, Dexacort, |
| Decadron Tablets, Elixir |
| Decadron-LA |
| Decadron, Dexamethasone |
| Decagel |
| Decaject |
| Decaject L.A. |
| Decaject-L.A. |
| Decalix |
| Decameth |
| Decasone |
| Decaspray |
| Dectancyl |
| Dekacort |
| delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol |
| delta1-9alpha-Fluoro-16alpha-methylcortisol |
| Deltafluorene |
| Dergramin |
| Deronil |
| Desadrene |
| Desametasone |
| Desametasone [DCIT] |
| Desamethasone |
| Desameton |
| Deseronil |
| Dex-ide |
| Dexa Mamallet |
| Dexa-Cortidelt |
| Dexa-Cortisyl |
| Dexa-Mamallet |
| Dexa-Scheroson |
| Dexa-sine |
| Dexacen-4 |
| Dexacidin |
| Dexacort |
| Dexacortal |
| Dexacortin |
| Dexadeltone |
| Dexafarma |
| Dexair |
| Dexalona |
| Dexaltin |
| Dexametasona |
| Dexametasona [INN-Spanish] |
| Dexametasone |
| Dexameth |
| Dexamethansone |
| dexamethasone |
| Dexamethasone Cyclodextrin complex |
| Dexamethasone (DHAP) |
| Dexamethasone (JP15/USP/INN) |
| Dexamethasone (JP17/USP/INN) |
| dexamethasone (tetramethyl-rhodamine conjugated ) |
| Dexamethasone [INN:BAN:JAN] |
| Dexamethasone [USP:INN:BAN:JAN] |
| Dexamethasone 1.0 mg/ml in Methanol |
| Dexamethasone alcohol |
| Dexamethasone Base |
| Dexamethasone for peak identification, European Pharmacopoeia (EP) Reference Standard |
| Dexamethasone for system suitability, European Pharmacopoeia (EP) Reference Standard |
| Dexamethasone Intensol |
| Dexamethasone solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material |
| Dexamethasone-omega |
| Dexamethasone, >=97.0% (HPLC) |
| Dexamethasone, >=98% (HPLC), powder |
| Dexamethasone, 98% 1g |
| Dexamethasone, European Pharmacopoeia (EP) Reference Standard |
| Dexamethasone, meets USP testing specifications |
| Dexamethasone, pharmaceutical secondary standard; traceable to USP, PhEur, BP |
| Dexamethasone, powder, BioReagent, suitable for cell culture, >=97% |
| Dexamethasone, powder, gamma-irradiated, BioXtra, suitable for cell culture, >=80% (HPLC) |
| Dexamethasone, tested according to Ph.Eur. |
| Dexamethasone, United States Pharmacopeia (USP) Reference Standard |
| Dexamethasone, VETRANAL(TM), analytical standard |
| Dexamethasonum |
| Dexamethasonum [INN-Latin] |
| Dexamethazone |
| Dexamonozon |
| Dexapolcort |
| Dexapos |
| Dexaprol |
| DexaSite |
| Dexason |
| Dexasone |
| Dexasone 0.5mg |
| Dexasone 0.75mg |
| Dexasone 4mg |
| Dexinolon |
| Dexinoral |
| dexmethsone |
| Dexone |
| Dexone 0.5 |
| Dexone 0.75 |
| Dexone 1.5 |
| Dexone 4 |
| Dexonium |
| Dexpak |
| Dextelan |
| Dextenza |
| Dezone |
| Dinormon |
| DSSTox_CID_384 |
| DSSTox_GSID_20384 |
| DSSTox_RID_75557 |
| DTXSID3020384 |
| DXM |
| DXM [Steroid] |
| Dxms |
| ECR Brand of Dexamethasone |
| EINECS 200-003-9 |
| EN300-52607 |
| Fluormethylprednisolone |
| Fluormone |
| Fluorocort |
| Fortecortin |
| Foy Brand of Dexamethasone |
| FT-0080377 |
| FT-0601576 |
| FT-0603100 |
| Gammacorten |
| GTPL2768 |
| GTPL3447 |
| Hexadecadrol |
| Hexadrol |
| Hexadrol Elixir |
| Hexadrol Tablets |
| Hl-dex |
| HMS1792A17 |
| HMS1990A17 |
| HMS2089N13 |
| HMS2235F08 |
| HMS3039L11 |
| HMS3259N11 |
| HMS3403A17 |
| HSDB 3053 |
| HY-14648 |
| I06-1196 |
| IBI-10090 |
| ICN Brand of Dexamethasone |
| IontoDex |
| Isopto-Dex |
| ISV-305 |
| J10029 |
| KS-000048I3 |
| KS-1451 |
| Lokalison F |
| Loverine |
| LS-7300 |
| Luxazone |
| Maxidex |
| Maxidex Ont 0.1% |
| Maxidex Sus 0.1% |
| Maxitrol |
| MCULE-4773827191 |
| Mediamethasone |
| Merck Brand of Dexamethasone |
| Merz Brand 1 of Dexamethasone |
| Merz Brand 2 of Dexamethasone |
| Methylfluorprednisolone |
| Mexidex |
| MFCD00064136 |
| Millicorten |
| MK 125 |
| MLS001055412 |
| MLS001332507 |
| MLS001332508 |
| MolMap_000018 |
| MolPort-003-846-433 |
| Mymethasone |
| Naquasone (Veterinary) |
| NC00645 |
| NCGC00091019-01 |
| NCGC00091019-02 |
| NCGC00091019-03 |
| NCGC00091019-04 |
| NCGC00091019-05 |
| NCGC00091019-06 |
| NCGC00091019-07 |
| NCGC00091019-08 |
| NCGC00257676-01 |
| NCI60_003067 |
| Neomycin and polymyxin b sulphates and dexamethasone |
| NSC 34521 |
| NSC-34521 |
| NSC34521 |
| Ocu-trol |
| Oradexon |
| Osurdex |
| OTO-104 |
| Pet Derm III |
| Pet-Derm Iii |
| PHL-dexamethasone |
| PL007868 |
| PMS Dexamethasone Elixir 0.5mg/5ml |
| PMS-dexamethasone |
| Policort |
| Posurdex |
| Prednisolon F |
| Prednisolone F |
| Prednisolone, 9.alpha.-fluoro-16.alpha.-methyl- |
| Prednisolone, 9alpha -fluoro-16alpha -methyl- |
| Prednisolone, 9alpha-fluoro-16alpha-methyl- |
| Pregna-1,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11.beta.,16.alpha.)- |
| Pregna-1,20-dione, 9-fluoro-11.beta.,17,21-trihydroxy-16.alpha.-methyl- |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11.beta.,16.alpha.)- |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11beta,16alpha)- |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, labeled with tritium, (11beta,16alpha)- |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11alpha -methyl- |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17,21-trihydroxy-16alpha-methyl- |
| Prodex |
| Q-200939 |
| s1322 |
| Sandoz Dexamethasone |
| SC-16127 |
| SCHEMBL3774 |
| SGCUT00126 |
| SK-Dexamethasone |
| SMP1_000092 |
| SMR000857119 |
| SMR001227192 |
| Spectrum5_002019 |
| Spoloven |
| ST24046431 |
| ST50307091 |
| Sunia Sol D |
| Superprednol |
| sustained-release dexamethasone |
| TL8003317 |
| to_000038 |
| Tox21_200122 |
| Tresaderm (Veterinary) |
| Turbinaire |
| UNII-7S5I7G3JQL |
| UREBDLICKHMUKA-CXSFZGCWSA-N |
| Visumetazone |
| W-5058 |
| WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1 |
| Z802671480 |
| ZINC3875332 |
US Patents and Regulatory Information for OZURDEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | OZURDEX | dexamethasone | IMPLANT;INTRAVITREAL | 022315-001 | Jun 17, 2009 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Allergan | OZURDEX | dexamethasone | IMPLANT;INTRAVITREAL | 022315-001 | Jun 17, 2009 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Allergan | OZURDEX | dexamethasone | IMPLANT;INTRAVITREAL | 022315-001 | Jun 17, 2009 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Allergan | OZURDEX | dexamethasone | IMPLANT;INTRAVITREAL | 022315-001 | Jun 17, 2009 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
International Patents for OZURDEX
Supplementary Protection Certificates for OZURDEX
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C/GB12/058 | United Kingdom | ➤ Sign Up | PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003 |
| C0012 | France | ➤ Sign Up | PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808 |
| C/GB12/047 | United Kingdom | ➤ Sign Up | PRODUCT NAME: DEXAMETHASONE; REGISTERED: UK EU/1/10/638/001 20100727 |
| 00552 | Netherlands | ➤ Sign Up | PRODUCT NAME: VOOR GEBRUIK IN EEN WERKWIJZE VOOR DE BEHANDELING VAN MACULAIR OEDEEM; REG. NO/DATE: EU/1/10/638/001 20100727 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
